EndeavorOTC

EndeavorOTC is clinically designed to improve ADHD symptoms, functioning, and attention in adults. It is indicated for adults 18 years and older with primarily inattentive or combined-type ADHD. The treatment involves playing the game for approximately 25 minutes a day, 5 days a week, for 6 weeks, with many participants showing substantial improvements in attention and clinical functioning with less playtime3.The clinical trial for EndeavorOTC reported no lasting or serious side effects, with the most common adverse device events being nausea and headache3.

The game-based treatmentis designedto be engaging and user-friendly. It challenges users to manage several tasks simultaneously, thereby improving attention pathways in the brain. The game's difficulty adjusts in real time as the player improves, ensuring that the challenge remains optimal for enhancing concentration.This design approachnot onlymakes the treatment engagingbut alsoensures that it is accessible and beneficial to the target audience3.

EndeavorOTC states they understand how important it is to protect your privacy. Akili uses industry standard privacy and security measures to protect your health data, in accordance with their Privacy Notice for the EndeavorOTC treatment.

EndeavorOTC's functionality is clearly outlined, with features designed to improve attention function in adults with ADHD. The content, delivered through an engaging video game experience, is based on decades of neuroscience research. It is designed to be accurate, complete, and appropriate for the target audience, ensuring that the health-related content supports the tool's underlying objective effectively23.

EndeavorOTCis builton the same technology as EndeavorRx, the first and only FDA-authorized video game to treat ADHD in children, suggesting a level of credibility and trust in the product's clinical utility2.The product receives periodic updates and maintenance to ensurebothtechnical functionality and content relevance.

Akili, the developer of EndeavorOTC, is known for its innovative approach to digital therapeutics. The company's focus on improving cognitive impairments through digital treatments demonstrates a commitment to ethical conduct, clinical responsibility, and adherence to regulations protecting patient rights3.

EndeavorOTC's interoperability and data integration capabilities are not explicitly detailed in the provided sources. However, digital health products often aim for compatibility with other health apps and electronic health records.

The product's design considers cultural relevance and accessibility, although specific details are not provided.

The cost of EndeavorOTC is $24.99 monthly or $124.99 annually, which includes a 7-day free trial for annual plans, indicating an effort to make the tool affordable 4.

The positive impact on adults with ADHD, especially in the context of medication shortages and therapy access challenges, suggests a favourable cost-benefit ratio 2.

The app's design for easy integration into daily routines without requiring additional resources for implementation further supports its practicality and effectiveness.